Reuters logo
NuPathe accepts Teva's takeover offer, ends deal with Endo
January 21, 2014 / 12:20 PM / 4 years ago

NuPathe accepts Teva's takeover offer, ends deal with Endo

Jan 21 (Reuters) - NuPathe Inc said it terminated its takeover deal with Endo Health Solutions Inc and accepted an offer from Israel’s Teva Pharmaceutical Industries Ltd .

Teva offered to buy the neurology drugs maker on Jan. 8 for $114 million plus milestone payments related to its Zecuity migraine treatment.

NuPathe said Teva’s offer represented a premium of about 28 percent over the upfront cash payment offered by Endo and equal amount of milestone-based payments.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below